share_log

康希諾生物：2023年股東週年大會的投票表決結果；及選舉第三屆董事會非執行董事

CANSINOBIO: POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING; AND ELECTION OF NON-EXECUTIVE DIRECTOR OF THIRD SESSION OF BOARD OF DIRECTORS

Hong Kong Stock Exchange ·  Jun 27 22:03
Summary by Futu AI
康希諾生物於2024年6月27日舉行的2023年股東週年大會上，所有提案均獲正式通過。會議中，李志成先生被選舉為第三屆董事會非執行董事。該次大會的出席股東所持股份數目約占已發行股份的34.29%，其中H股和A股的出席比例分別為29.12%和40.28%。會議通過的重要決議包括董事會報告、監事會報告、年度報告及其摘要、財務決算報告及財務審計報告、利潤分配方案、重新委任德勤為2024年度國際核數師等。此外，還通過了關於未彌補虧損、股東分紅回報規劃、董事會一般授權、發行債務融資工具等議案。監票工作由香港中央證券登記有限公司負責，並有股東代表、律師及監事參與。董事會成員包括執行董事Xuefeng YU博士、Shou Bai CHAO博士、王靖女士，非執行董事李志成先生，以及獨立非執行董事桂水發先生、劉建忠先生及張耀樑先生。
康希諾生物於2024年6月27日舉行的2023年股東週年大會上，所有提案均獲正式通過。會議中，李志成先生被選舉為第三屆董事會非執行董事。該次大會的出席股東所持股份數目約占已發行股份的34.29%，其中H股和A股的出席比例分別為29.12%和40.28%。會議通過的重要決議包括董事會報告、監事會報告、年度報告及其摘要、財務決算報告及財務審計報告、利潤分配方案、重新委任德勤為2024年度國際核數師等。此外，還通過了關於未彌補虧損、股東分紅回報規劃、董事會一般授權、發行債務融資工具等議案。監票工作由香港中央證券登記有限公司負責，並有股東代表、律師及監事參與。董事會成員包括執行董事Xuefeng YU博士、Shou Bai CHAO博士、王靖女士，非執行董事李志成先生，以及獨立非執行董事桂水發先生、劉建忠先生及張耀樑先生。
At the shareholder annual meeting in 2023 held on June 27, 2024, all proposals were officially passed. During the meeting, Mr. Li Zhicheng was elected as the third board of directors non-executive director. The attending shareholders at the meeting held approximately 34.29% of the issued shares, with attendance proportions of 29.12% and 40.28% for H shares and A shares respectively. Important resolutions passed at the meeting include the board of directors report, supervisor's report, annual report and its summary, financial statements and financial audit reports, profit distribution plan, as well as reappointing Deloitte as the international auditor for 2024. In addition, proposals were passed regarding the uncompensated losses, shareholder dividend return plan, general authorization of the board of directors, and issuance of debt financing instruments...Show More
At the shareholder annual meeting in 2023 held on June 27, 2024, all proposals were officially passed. During the meeting, Mr. Li Zhicheng was elected as the third board of directors non-executive director. The attending shareholders at the meeting held approximately 34.29% of the issued shares, with attendance proportions of 29.12% and 40.28% for H shares and A shares respectively. Important resolutions passed at the meeting include the board of directors report, supervisor's report, annual report and its summary, financial statements and financial audit reports, profit distribution plan, as well as reappointing Deloitte as the international auditor for 2024. In addition, proposals were passed regarding the uncompensated losses, shareholder dividend return plan, general authorization of the board of directors, and issuance of debt financing instruments. The vote counting was handled by Hong Kong Securities Clearing Company Limited with the participation of shareholder representatives, lawyers, and supervisors. The board of directors members include executive directors Dr. Xuefeng YU, Dr. Shou Bai CHAO, and Ms. Jing WANG, non-executive director Mr. Li Zhicheng, and independent non-executive directors Mr. Shuifa GUI, Mr. Jianzhong LIU, and Mr. Yaoliang ZHANG.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.